Prevention of Breast Cancer (Part I): Epidemiology, Risk Factors, and Risk Assessment Tools, Cancer Investigation, vol.67, issue.17, pp.743-750, 2010. ,
DOI : 10.1038/sj.bjc.6604305
Circulating tumour markers in breast cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.31, issue.0, pp.15-22, 2002. ,
DOI : 10.1007/s00259-004-1523-z
Monitoring the Circulating Levels of the HER2/neu Oncoprotein in Breast Cancer, Clinical Breast Cancer, vol.5, issue.2, pp.105-116, 2004. ,
DOI : 10.3816/CBC.2004.n.014
Emerging Technologies for HER2 Testing, Oncology, vol.63, issue.1, pp.33-38, 2002. ,
DOI : 10.1159/000066199
Antibody array-based technologies for cancer protein profiling and functional proteomic analyses using serum and tissue specimens, Tumor Biology, vol.520, issue.2, pp.103-112, 2010. ,
DOI : 10.1007/s13277-009-0014-z
Cytometric bead array: a multiplexed assay platform with applications in various areas of biology, Clinical Immunology, vol.110, issue.3, pp.252-266, 2004. ,
DOI : 10.1016/j.clim.2003.11.017
Antibody Suspension Bead Arrays within Serum Proteomics, Journal of Proteome Research, vol.7, issue.8, pp.3168-3179, 2008. ,
DOI : 10.1021/pr700890b
Naturally occurring antibodies devoid of light chains, Nature, vol.363, issue.6428, pp.446-448, 1993. ,
DOI : 10.1038/363446a0
: proficient tools in diagnostics, Expert Review of Molecular Diagnostics, vol.10, issue.6, pp.777-785, 2010. ,
DOI : 10.1586/erm.10.62
Immuno-imaging using nanobodies, Current Opinion in Biotechnology, vol.22, issue.6, pp.877-881, 2011. ,
DOI : 10.1016/j.copbio.2011.06.009
Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen, FEBS Journal, vol.31, issue.14, pp.3881-3893, 2009. ,
DOI : 10.1111/j.1742-4658.2009.07101.x
URL : https://hal.archives-ouvertes.fr/hal-00414287
A single-step procedure of recombinant library construction for the selection of efficiently produced llama VH binders directed against cancer markers, Journal of Immunological Methods, vol.350, issue.1-2, pp.54-62, 2009. ,
DOI : 10.1016/j.jim.2009.08.016
Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumor cells: selection of specific antibodies from single-chain Fv fusion phage libraries., Proceedings of the National Academy of Sciences, vol.92, issue.14, pp.6537-6541, 1995. ,
DOI : 10.1073/pnas.92.14.6537
Identification of colon tumour-associated antigens by phage antibody selections on primary colorectal carcinoma, European Journal of Cancer, vol.37, issue.4, pp.542-549, 2001. ,
DOI : 10.1016/S0959-8049(00)00432-9
De novo identification of tumor-specific internalizing human antibody???receptor pairs by phage-display methods, Journal of Immunological Methods, vol.274, issue.1-2, pp.185-197, 2003. ,
DOI : 10.1016/S0022-1759(02)00522-7
A proteomic approach to tumour target identification using phage display, affinity purification and mass spectrometry, European Journal of Cancer, vol.41, issue.1, pp.178-187, 2005. ,
DOI : 10.1016/j.ejca.2004.10.008
Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library, Journal of Immunological Methods, vol.248, issue.1-2, pp.17-30, 2001. ,
DOI : 10.1016/S0022-1759(00)00340-9
Mapping Tumor Epitope Space by Direct Selection of Single-Chain Fv Antibody Libraries on Prostate Cancer Cells, Cancer Research, vol.64, issue.2, pp.704-710, 2004. ,
DOI : 10.1158/0008-5472.CAN-03-2732
Phage Libraries ??? A New Route to Clinically Useful Antibodies, New England Journal of Medicine, vol.335, issue.10, pp.730-733, 1996. ,
DOI : 10.1056/NEJM199609053351008
Breast carcinoma specific antibody selection combining phage display and immunomagnetic cell sorting, Biochemical and Biophysical Research Communications, vol.348, issue.2, pp.550-559, 2006. ,
DOI : 10.1016/j.bbrc.2006.07.087
Determination of the binding affinity of an anti-CD34 single-chain antibody using a novel, flow cytometry based assay, 38. K. Even-Desrumeaux, D. Baty and P. Chames, pp.223-231, 1997. ,
DOI : 10.1016/S0022-1759(96)00227-X
Clinical utility of cytokeratins as tumor markers, Clinical Biochemistry, vol.37, issue.7, pp.529-540, 2004. ,
DOI : 10.1016/j.clinbiochem.2004.05.009
Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: relevance for circulating tumor cell detection, Journal of Experimental & Clinical Cancer Research, vol.28, issue.1, pp.57-101, 2009. ,
DOI : 10.1186/1756-9966-28-57
Generation of llama single-domain antibodies against methotrexate, a prototypical hapten, 46. A. Shevchenko, M. Wilm, O. Vorm and M. Mann, pp.1680-1690, 1996. ,
DOI : 10.1016/j.molimm.2006.08.007
URL : https://hal.archives-ouvertes.fr/hal-00258931